ArticleScientific reports2025
Chemical finger-printing, antioxidant activity and in silico validation of phytometabolites of Octhochloa compressa.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Troxerutin, a herbal metabolite with antidiabetic and antihypercholesterolemic potential, regulates metabolic gene activity in male diabetic rats.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study focused on evaluating the antioxidant properties of Octhochloa compressa, a Cholistani medicinal plant and to explore the interaction of its active phytochemical constituents with the biological macromolecule NADPH oxidase (PDB ID: 2CDU). Six different non-polar to polar solvent extracts were evaluated for their antioxidant activity using DPPH and FRAP assays. The key metabolites were then subjected to molecular docking against NADPH oxidase, density functional theory (DFT) and molecular dynamics (MD) simulations to validate the ligand-protein stability and conformational dynamics. The methanol extract revealed significantly highest scavenging potential (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.